1887

Abstract

The role of T cells in immunity to foot-and-mouth disease virus is still poorly defined compared to that of the humoral response. In this paper we describe a systematic, longitudinal study on the cellular recognition of FMDV and its subunit protein VP1 by bovine peripheral blood T lymphocytes. Multiple vaccination with a single virus serotype induced a serotype cross-reactive proliferative T cell repertoire that varied in magnitude between individual animals and with the serotype of the vaccine used. Primary proliferative T cell responses of vaccinated and acutely infected cattle were weak relative to the magnitude of responses determined for the same animals after boosting. In contrast, the level of circulating antibody produced after both primary and secondary exposure to virus was good. Phenotypic analysis of lymphocytes from vaccinated or infected cattle showed a small increase in CD8 T cells after infection compared to vaccination. However, in general the profiles of circulating lymphocytes elicited were similar. Thus, we were not able to use proliferative or phenotypic analyses to distinguish between vaccinated and convalescent cattle. T cell recognition of VP1 by multiply-vaccinated cattle was serotype-specific implying that the cross-reactive responses observed with whole virus may be attributed to proteins other than VP1. In contrast to other studies, immunization with recombinant VP1 induced only low levels of neutralizing antibody and failed to elicit profound proliferative responses or protection even after two immunizations.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-77-4-727
1996-04-01
2024-04-23
Loading full text...

Full text loading...

/deliver/fulltext/jgv/77/4/JV0770040727.html?itemId=/content/journal/jgv/10.1099/0022-1317-77-4-727&mimeType=html&fmt=ahah

References

  1. Acharya R., Fry E., Stuart D., Fox G., Rowlands D., Brown F. 1989; The three-dimensional structure of foot-and-mouth disease virus at 2.9 Å resolution. Nature 337:709–716
    [Google Scholar]
  2. Bachrach H. L., Moore D. M., McKercher P. D., Polatnick J. 1975; Immune and antibody responses to an isolated capsid protein of foot-and-mouth disease virus. Journal of Immunology 115:1636–1641
    [Google Scholar]
  3. Bachrach H. L., Morgan D. O., Moore D. M. 1979; Foot-and-mouth disease virus immunogenic capsid protein VPT: N-terminal sequences and immunogenic peptides obtained by CNBr and tryptic cleavages. Intervirology 12:65–72
    [Google Scholar]
  4. Bachrach H. L., Morgan D. O., McKercher P. D., Moore D. M., Robertson B. H. 1982; Foot-and-mouth disease virus: immunogenicity and structure of fragments derived from capsid protein VP3 and of virus containing cleaved VP3. Veterinary Microbiology 7:85–96
    [Google Scholar]
  5. Bartels T., Schafer H., Liebermann H., Burger R., Beyer J. 1994; T-lymphocyte responses in guinea pigs vaccinated with foot-and-mouth disease virus. Veterinary Immunology and Immunopathology 40:213–223
    [Google Scholar]
  6. van Bekkum J. G. 1969; Correlation between serum antibody level and protection against challenge with F,. M,. D. virus. European Commission for the control of foot.and.mouth disease. Report of the meeting of Research Group of the Standing Technical Committee Brescia, Italy:
    [Google Scholar]
  7. Bittle J. L., Houghten R. A., Alexander H., Shinnick T. M., Sutcliffe J. G., Lerner R. A. 1982; Protection against foot-and-mouth disease by immunization with a chemically synthesized peptide predicted from the viral nucleotide sequence. Nature 298:30–33
    [Google Scholar]
  8. Borca M. V., Fernandez F. M., Sadir A. M., Braun M., Schudel A. A. 1986; Immune response to foot-and-mouth disease virus in a murine experimental model: effective thymus-independent primary and secondary reaction. Immunology 59:261–267
    [Google Scholar]
  9. Broekhuijsen M. P., van Rijn J. M. M., Blom A. J. M., Pouwels P. H., Enger-Valk B. E., Brown F., Francis M. J. 1987; Fusion proteins with multiple copies of the major antigenic determinant of foot-and-mouth disease virus protect both natural host and laboratory animals. Journal of General Virology 68:3137–3143
    [Google Scholar]
  10. Burroughs J. N., Rowlands D. J., Sangar D. V., Talbot P., Brown F. 1971; Further evidence for multiple proteins in the foot-and-mouth disease virus particle. Journal of General Virology 13:73–84
    [Google Scholar]
  11. Cartwright B., Chapman W. G., Sharpe R. T. 1982; Stimulation by heterotypic antigens of foot-and-mouth disease virus antibodies in vaccinated cattle. Research in Veterinary Science 32:338–342
    [Google Scholar]
  12. Collen T., Doel T. R. 1990; Heterotypic recognition of foot-and-mouth disease virus by cattle lymphocytes. Journal of General Virology 71:309–315
    [Google Scholar]
  13. Collen T., Pullen L., Doel T. R. 1989; T cell-dependent induction of antibody against foot-and-mouth disease virus in a mouse model. Journal of General Virology 70:395–403
    [Google Scholar]
  14. Collen T., DiMarchi R., Doel T. R. 1991; A T cell epitope in VP1 of foot-and-mouth disease virus is immunodominant for vaccinated cattle. Journal of Immunology 146:749–755
    [Google Scholar]
  15. Cunliffe H. R. 1962; Antibody response in a group of swine after infection with foot-and-mouth disease virus. Canadian Journal of Comparative Medical and Veterinary Science 26:182–185
    [Google Scholar]
  16. DiMarchi R., Brooke G., Gale C., Cracknell V., Doel T. R., Mowat N. 1986; Protection of cattle against foot-and-mouth disease by a synthetic peptide. Science 232:639–641
    [Google Scholar]
  17. Francis M. J., Fry C. M., Rowlands D. J., Brown F., Bittle J. L., Houghten R. A., Lerner R. A. 1985; Immunological priming with synthetic peptides of foot-and-mouth disease virus. Journal of General Virology 66:2347–2354
    [Google Scholar]
  18. Garland A. J. M. 1974 The inhibitory activity of secretions in cattle against foot and mouth disease virus Ph.D thesis, London School of Hygiene and Tropical Medicine, University of London;
    [Google Scholar]
  19. Glass E. J., Oliver R. A., Collen T., Doel T. R., DiMarchi R., Spooner R. L. 1991; MHC class II restricted recognition of FMDV peptides by bovine T cells. Immunology 74:594–599
    [Google Scholar]
  20. Golding S. M., Hedger R. S., Talbot P., Watson J. 1976; Radial immune-diffusion and serum-neutralisation techniques for the assay of antibodies to swine vesicular disease. Research in Veterinary Science 20:142–147
    [Google Scholar]
  21. Gomes I., Fernandez A. A., DeMello P. A. 1972; Foot-and-mouth disease circulating antibodies in convalescent cattle. Bulletin de Office des International Epizooties 77:731–741
    [Google Scholar]
  22. Howard C. J., Morrison W. I., Bbnsaid A., Davis W., Eskra L., Gerdes J., Hadam M., Hurley D., Leibold W., Letesson J. J., MacHugh N., Naessens J., O’Reilly K., Parsons K. R., Schlote D., Sopp P., Splitter G., Wilson R. 1991; Summary of workshop findings for leukocyte antigens of cattle. Veterinary Immunology and Immunopathology 11:21–27
    [Google Scholar]
  23. King A. M. Q., Newman J. W. I. 1980; Temperature sensitive mutants of foot-and-mouth disease virus with altered structural polypeptides. I. Identification by electro-focusing. Journal of Virology 34:59–66
    [Google Scholar]
  24. Kleid D. G., Yansura D. G., Small B., Dowbenko D., Moore D. M., Grubman M. J., McKercher P. D., Morgan D. O., Robertson B. H., Bachrach H. L. 1981; Cloned viral protein vaccine for foot-and-mouth disease: responses in cattle and swine. Science 214:1125–1129
    [Google Scholar]
  25. Kleid D. G., Yansura D. G., Dowbenko D., Weddell G. N., Hoatlin M. E., Clayton N., Shire S. J., Bock L. A., Ogez J., Builder S., Patzer E. J. 1984; Cloned viral protein for control of foot-and-mouth disease. Developments in Industrial Microbiology 25:317–325
    [Google Scholar]
  26. Knudsen R. C., Groocock C. M., Anderson A. A. 1979; Immunity to foot-and-mouth disease virus in guinea pigs: clinical and immune responses. Infection and Immunity 24:787–792
    [Google Scholar]
  27. Laemmli U. K. 1970; Cleavage of structural proteins during assembly of the head of bacteriophage T4. Nature 111:680–683
    [Google Scholar]
  28. Laporte J., Grosclaude J., Wantyghem J., Bernard S., Rouze P. 1973; Neutralisation en culture cellulaire du pouvoir infectieux du virus de la fièvre aphteuse par des serums provenant de pores immunizès a 1’aide d’une proteine virale purifièe. Compte rendu hebdomadaire des sèances de TAcadèmie des Sciences 276D:3399–3401
    [Google Scholar]
  29. Van Lierop M.-J. C., van Maanen K., Meloen R. H., Rutten V. P. M. G., de Jong M. A. C., Hensen E. J. 1992; Proliferative lymphocyte responses to foot-and-mouth disease virus and three FMDV peptides after vaccination or immunization with these peptides in cattle. Immunology 75:406–413
    [Google Scholar]
  30. van Lierop M.-J. C., van Noort J. M., Wagenaar J. P., Rutten V. P. M. G., Langeveld J., Meloen R. H., Hensen E. J. 1994; T cell-stimulatory fragments of foot-and-mouth disease virus released by mild treatment with cathepsin D. Journal of General Virology 75:2937–2946
    [Google Scholar]
  31. McCullough K. C., Crowther J. R., Butcher R. N., Carpenter W. C., Brocchi E., Capucci L., de Simone F. 1986; Immune protection against foot-and-mouth disease virus studied using virus-neutralizing and non-neutralizing concentrations of monoclonal antibodies. Immunology 58:421–428
    [Google Scholar]
  32. McKercher P. D., Moore D. M., Morgan D. O., Robertson B. H., Callis J. J., Kleid D. G., Shire S. J., Yansura D. G., Dowbenko D., Small B. 1985; Dose-response evaluation of a genetically engineered foot-and-mouth disease virus polypeptide immunogen in cattle. American Journal of Veterinary Research 46:587–590
    [Google Scholar]
  33. Meloen R. H. 1979a; Antibody response against foot-and-mouth disease virus. I. Responses measured in sera of vaccinated steers with complete virus, trypsin treated virus, 12S virus subunits, VIA and heterologous virus. Zentralblatt für Veterinärmedizin 26:273–283
    [Google Scholar]
  34. Meloen R. H. 1979b; Antibody response against foot-and-mouth disease virus. II. Responses measured in fractionated sera of infected steers with complete virus, trypsin treated virus, 12S virus subunits, VIA and heterologous virus. Zentralblatt für Veterinärmedizin 26:358–365
    [Google Scholar]
  35. Pay T. W. F., Hingley P. J. 1992; A potency test method for foot and mouth disease vaccine based on the serum neutralizing antibody response produced in cattle. Vaccine 10:707–713
    [Google Scholar]
  36. Ryan M. D., Belsham G. J., King A. M. Q. 1989; Specificity of enzyme substrate interactions in foot-and-mouth disease virus polyprotein processing. Virology 173:35–45
    [Google Scholar]
  37. Saiz J. C., Rodriguez A., Gonzalez M., Alonso F., Sobrino F. 1992; Heterotypic lymphoproliferative response in pigs vaccinated with foot-and-mouth disease virus. Involvement of isolated capsid proteins. Journal of General Virology 73:2601–2607
    [Google Scholar]
  38. Shire S. J., Bock L., Ogez J., Builder S., Kleid D., Moore D. M. 1984; Purification and immunogenicity of fusion VP1 of foot and mouth disease virus. Biochemistry 23:6474–6480
    [Google Scholar]
  39. Strohmaier K., Franze R., Adam K.-H. 1982; Location and characterization of the antigenic portion of the FMDV immunizing protein. Journal of General Virology 59:295–306
    [Google Scholar]
  40. Townsend A., Bodmer H. 1989; Antigen recognition by class I-restricted T-lymphocytes. Annual Review of Immunology 7:601–624
    [Google Scholar]
  41. Wardley R. C., Chapman W. G., Garland A. J. M. 1979; A blastogenic test for foot-and-mouth disease. Journal of Hygiene 83:507–512
    [Google Scholar]
  42. Yansura D. G., Dowbenko D., Weddell G. N., Hoatlin M. E., Shire S. J., Bock L. A., Patzer E. J., Kleid D. G. 1983; Biosynthetic vaccine for foot-and-mouth disease. In Proceedings of the Miami Winter Symposium 20. Advances in Gene Technology: Molecular Genetics of Plants and Animals pp 479–493 New York: Academic Press;
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-77-4-727
Loading
/content/journal/jgv/10.1099/0022-1317-77-4-727
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error